Copied
 
 
2023, DKK
28.02.2024
Bruttoresultat

8.248'

Primær drift

2.674'

Årets resultat

2.651'

Aktiver

28.301'

Kortfristede aktiver

22.618'

Egenkapital

14.550'

Afkastningsgrad

9 %

Soliditetsgrad

51 %

Likviditetsgrad

164 %

Resultat
28.02.2024
Årsrapport
2023
28.02.2024
2022
16.03.2023
2021
20.04.2022
2020
22.03.2021
2019
07.04.2020
2018
08.05.2019
2017
28.03.2018
2016
21.04.2017
2015
22.03.2016
Nettoomsætning
Bruttoresultat8.247.8997.093.7416.870.4168.899.5687.942.3957.872.1189.039.7098.381.5362.855.326
Resultat af primær drift2.674.0452.458.5761.944.9203.172.2271.666.6381.648.4511.697.673583.109-3.151.757
Indtægter af kapitalandele (tilknyttede og associerede) 000000000
Finansielle indtægter7.0455.5855.1321.22113.3960021.2670
Finansieringsomkostninger-30.293-52.905-51.374-68.669-827.422-857.081-161.237-20.889-47.213
Andre finansielle omkostninger000000000
Resultat før skat2.650.7972.411.2561.898.6783.104.779852.612791.3701.536.436583.487-3.198.970
Resultat2.650.7972.411.2561.898.6783.104.779852.612791.3701.536.436583.487-3.198.970
Forslag til udbytte000000000
Aktiver
28.02.2024
Årsrapport
2023
28.02.2024
2022
16.03.2023
2021
20.04.2022
2020
22.03.2021
2019
07.04.2020
2018
08.05.2019
2017
28.03.2018
2016
21.04.2017
2015
22.03.2016
Kortfristede varebeholdninger6.367.6403.566.7564.376.8555.970.9717.390.4143.111.431000
Kortfristede tilgodehavender fra salg og tjenesteydelser 11.265.11211.254.9109.062.6699.551.9139.340.96110.146.65813.588.32012.609.9447.591.311
Likvider4.985.1504.123.004684.3523.810.2034.253.96335.758.46936.156.0672.684.1961.862.829
Kortfristede aktiver22.617.90218.944.67014.123.87619.333.08720.985.33849.016.55849.744.38715.294.1409.454.140
Immaterielle aktiver og goodwill000000000
Finansielle anlægsaktiver194.147178.6150000000
Materielle aktiver5.489.0975.546.1355.603.1735.660.2115.717.2515.871.8916.015.685282.691381.212
Langfristede aktiver5.683.2445.724.7505.603.1735.660.2115.717.2515.871.8916.015.685282.691381.212
Aktiver28.301.14624.669.42019.727.04924.993.29826.702.58954.888.44955.760.07215.576.8319.835.352
Aktiver
28.02.2024
Passiver
28.02.2024
Årsrapport
2023
28.02.2024
2022
16.03.2023
2021
20.04.2022
2020
22.03.2021
2019
07.04.2020
2018
08.05.2019
2017
28.03.2018
2016
21.04.2017
2015
22.03.2016
Forslag til udbytte000000000
Egenkapital14.550.40411.899.6079.488.3517.589.6734.484.8943.632.2822.840.9101.304.474-5.555.413
Hensatte forpligtelser000000000
Langfristet gæld til banker000000000
Anden langfristet gæld118.384435.892435.892215.6920000
Leverandører af varer og tjenesteydelser12.513.53611.777.9665.304.2217.721.32814.928.16916.434.32917.628.96511.817.73614.017.786
Kortfristede forpligtelser13.750.74212.651.4299.802.80616.967.73322.002.00317.483.92319.356.53314.272.35715.390.765
Gældsforpligtelser13.750.74212.769.81310.238.69817.403.62522.217.69551.256.16752.919.16214.272.35715.390.765
Forpligtelser13.750.74212.769.81310.238.69817.403.62522.217.69551.256.16752.919.16214.272.35715.390.765
Passiver28.301.14624.669.42019.727.04924.993.29826.702.58954.888.44955.760.07215.576.8319.835.352
Passiver
28.02.2024
Nøgletal
28.02.2024
Årsrapport
2023
28.02.2024
2022
16.03.2023
2021
20.04.2022
2020
22.03.2021
2019
07.04.2020
2018
08.05.2019
2017
28.03.2018
2016
21.04.2017
2015
22.03.2016
Afkastningsgrad 9,4 %10,0 %9,9 %12,7 %6,2 %3,0 %3,0 %3,7 %-32,0 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 18,2 %20,3 %20,0 %40,9 %19,0 %21,8 %54,1 %44,7 %57,6 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal 8.827,3 %4.647,2 %3.785,8 %4.619,6 %201,4 %192,3 %1.052,9 %2.791,5 %-6.675,6 %
Soliditestgrad 51,4 %48,2 %48,1 %30,4 %16,8 %6,6 %5,1 %8,4 %-56,5 %
Likviditetsgrad 164,5 %149,7 %144,1 %113,9 %95,4 %280,4 %257,0 %107,2 %61,4 %
Resultat
28.02.2024
Gæld
28.02.2024
Årsrapport
28.02.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 28.02.2024)
Information om virksomhedens regnskabsklasse:The annual report for Cell Biotech International A/S has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises. The accounting policies are unchanged from last year, and the annual report is presented in DKK.
Oplysning om pantsætninger og sikkerhedsstillelser:5. Charges and security As security for the total balances with the bank, mortgage has been granted on one of the company's accounts representing a book value of t.DKK 147 at 31 December 2023.
Beretning
28.02.2024
Dato for ledelsens godkendelse af årsrapporten:2024-02-22
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Managing Director have approved the annual report of Cell Biotech International A/S for the financial year 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Description of key activities of the company In the financial year the company's activity has consisted of trading probiotics, cosmetics, food supplement and general food.